Spruce Biosciences, Inc.
SPRB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $43 | $162 | $220 |
| - Cash | $10,669 | $16,387 | $25,615 | $38,753 |
| + Debt | $500 | $1,823 | $2,295 | $2,765 |
| Enterprise Value | – | -$14,521 | -$23,158 | -$35,768 |
| Revenue | $0 | $0 | $0 | $697 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $697 |
| % Margin | – | – | – | 100% |
| EBITDA | -$8,190 | -$2,031 | -$13,999 | -$23,494 |
| % Margin | – | – | – | -3,370.7% |
| Net Income | -$8,212 | -$2,067 | -$14,041 | -$23,559 |
| % Margin | – | – | – | -3,380.1% |
| EPS Diluted | -14.58 | -3.41 | -24 | -43.5 |
| % Growth | -327.6% | 85.8% | 44.8% | – |
| Operating Cash Flow | -$5,316 | -$8,828 | -$12,727 | -$20,677 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$5,316 | -$8,828 | -$12,727 | -$20,677 |